NovoCure Limited

NovoCure Limited

World Rank (Jan-05-2024)
6,926
Market Cap (Jan-05-2024)
1.443 Billion USD
World Rank (Jul-30-2023)
3,876
Market Cap (Jul-30-2023)
3.539 Billion USD
World Rank (Jan-07-2022)
2,542
Market Cap (Jan-07-2022)
6.878 Billion USD
World Rank (Jan-01-2021)
1,022
Market Cap (Jan-01-2021)
17.615 Billion USD
Company Rank in Country in 2023
Company rank in UK in July-2023 is 138
Headquarters Country
UK
Nasdaq / NYSE Code
NVCR
Market Cap (Mar-08-2026)
1.48
Employee Count
1,023
Employee Count as of Date
As on 2020
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
535 Million USD
Annual Net Income in USD
-58 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
1,139 Million USD
Total Liabilities in USD
729 Million USD
Total Equity in USD
410 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Company Website
NOVOCURE LIMITED
Yahoo
Yahoo @ Nasdaq
Company Profile

Manufactures medical equipment related to treating tumors. Headquarters is in Jersey.

Annual Results Summary

NOVOCURE - Annual Results - Revenue and Profit - in Million USD:

Year EndingRevenueNet Income
Dec-2022537-92 (Loss)
Dec-2021535-58.3 (Loss)
Dec-202049419.8
Dec-2019351-7.2 (Loss)
Dec-2018248-63.5 (Loss)
Dec-2017177-61.6 (Loss)
Balance Sheet Summary

NOVOCURE - Balance Sheet Summary - in Million USD:

Total Assets as on Dec-2022 was 1,191 Million USD.

Total Liabilities as on Dec-2022 was 750 Million USD.

Total Equity as on Dec-2022 was 441 Million USD.

Founded Year
2000
IPO Year
2015
Stock Exchange
Nasdaq
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share